Astrazeneca Ab

Saint Louis University

Quretech Bio Ab

Washington University

Fritiof Pontén

Gert Strandlund

Peder Svensson

Kurt-Jürgen Hoffmann

Magnus Björsne

Michael Wilstermann

Kelly Flentie

David Cladingboel

Fredrik Almqvist

John Pavey

Annika Björe

Colin Thomson

Michael Wilsterman

Christina Leigh Stallings

James Arthur Dudley Good

Magnus Bjorsne

Christina L Stallings

The present disclosure provides a combination comprising: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable combination thereof. The combination may be used in the treatment and/or prevention of tuberculosis.

Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis

There is provided compounds of formula I, wherein R, R, R, R, Rto R, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

Oxabispidine compounds useful in the treatment of cardiac arrhythmias

There is provided compounds of formula (I) wherein Rto R, Rto R, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias

There is provided compounds of formula (I), wherein R, Rand Rto Rhave meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias

Growing community of inventors

Askim, Sweden

Fritiof Pontén